Surgical Outcomes of Gonioscopy-assisted Transluminal Trabeculotomy (GATT) in Patients With Open-angle Glaucoma. Issue 12 (December 2017)

• Record Type: Journal Article
• Authors: Rahmatnejad, Kamran; Pruzan, Noelle L.; Amanullah, Sarah; Shaukat, Bilal A.; Resende, Arthur F.; Waisbourd, Michael; Zhan, Tingting; Moster, Marlene R.
• Is Part Of: Journal of glaucoma. Volume 26:Issue 12(2017)
• Publication Date: 2017-12
• Subjects: glaucoma surgery -- gonioscopy-assisted -- trabeculotomy -- minimally invasive -- transluminal; Glaucoma -- Periodicals; 617.741005
• DOI: 10.1097/IJG.0000000000000802
• Languages: English
• ISSNs: 1057-0829

Abstract

Abstract : Purpose: To evaluate the efficacy and safety of gonioscopy-assisted transluminal trabeculotomy (GATT) in patients with open-angle glaucoma. Participants and Methods: A retrospective chart review of adult patients who underwent GATT due to inadequately controlled intraocular pressure (IOP) or intolerance to medication. Main outcome measures were success rate, IOP, and number of glaucoma medications. Success was defined as IOP reduction >20% from baseline or IOP between 5 to 21 mm Hg, and no need for further glaucoma surgery. When success criteria were not met for any postoperative visit >3 months after surgery, failure was determined. Results: In total, 66 patients, average age 62.9±14.9 years (50.8% female) were included in the analysis. Average follow-up was 11.9 months (range, 3 to 30 mo) and overall success rate was 63.0%. Mean IOP was 26.1±9.9 mm Hg preoperatively and 14.6±4.7 mm Hg at 12 months (44% IOP decrease; P <0.001). Mean number of medications decreased from 3.1±1.1 preoperatively to 1.2±0.9 at 12 months ( P <0.001). No significant differences between patients with primary open-angle glaucoma and other types of glaucoma were found. The rate of hyphema at 1 week and 1 month postoperatively was 38% and 6%, respectively. Overall GATT success rate among white and black patients was 69% and 42%, respectively, which was statistically significant ( P <0.05). Conclusions: The future of GATT as a minimally invasive glaucoma surgery in adults seems promising. This position is supported by its low rate of long-term complications and the conjunctiva-sparing nature of the surgery.